Paradigm Biopharmaceuticals's total assets for Q4 2025 were AU$24.57M, a decrease of -30.50% from the previous quarter. AU:PAR total liabilities were AU$3.39M for the fiscal quarter, a 160.25% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.